Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

ASHWIN MURIGEPPA SHEELVANTH

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1134115769
CMS profile
142231
Location
ZION, IL

General Payments · PY2019–2025

$5,648.92

  • Reported across 270 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$414.63

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $414.63 16

By paying entity

PY2025 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $367.15 33
PY2022 $1,417.24 71
PY2023 $1,893.28 84
PY2024 $1,556.62 66
PY2025 $414.63 16

Payment records · PY2025 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2025 2019202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Adaptive Biotechnologies Corporation $26.82 02/05/2025 Food and Beverage Undisputed 06/30/2026 1254933763 CMS
Alexion Pharmaceuticals, Inc. $20.33 02/03/2025 Food and Beverage Undisputed 06/30/2026 1202978220 CMS
Alexion Pharmaceuticals, Inc. $20.33 03/10/2025 Food and Beverage Undisputed 06/30/2026 1202932410 CMS
ARRAY BIOPHARMA INC $21.95 01/15/2025 Food and Beverage Undisputed 06/30/2026 1231113353 CMS
Astellas Pharma US Inc $24.27 03/05/2025 Food and Beverage Undisputed 06/30/2026 1238743754 CMS
AstraZeneca Pharmaceuticals LP $21.61 02/10/2025 Food and Beverage Undisputed 06/30/2026 1206734865 CMS
Daiichi Sankyo Inc. $23.79 02/27/2025 Food and Beverage Undisputed 06/30/2026 1197048933 CMS
GlaxoSmithKline, LLC. $31.80 01/28/2025 Food and Beverage Undisputed 06/30/2026 1190467157 CMS
Janssen Biotech, Inc. $22.49 02/20/2025 Food and Beverage Undisputed 06/30/2026 1174345136 CMS
Merck Sharp & Dohme LLC $24.15 01/16/2025 Food and Beverage Undisputed 06/30/2026 1238357401 CMS
Merck Sharp & Dohme LLC $17.51 02/04/2025 Food and Beverage Undisputed 06/30/2026 1238178333 CMS
Novartis Pharmaceuticals Corporation $23.66 02/19/2025 Food and Beverage Undisputed 06/30/2026 1200450435 CMS
PFIZER INC. $27.42 03/17/2025 Food and Beverage Undisputed 06/30/2026 1231476316 CMS
SOBI, INC $57.82 01/14/2025 Food and Beverage Undisputed 06/30/2026 1240232815 CMS
SOBI, INC $28.49 03/11/2025 Food and Beverage Undisputed 06/30/2026 1240232820 CMS
Sumitomo Pharma America, Inc. $22.19 02/14/2025 Food and Beverage Undisputed 06/30/2026 1176719886 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2019 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.